Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 26% ± 12% |
Insufficient scRNA-seq data for expression of ARSL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 98% | 2232.46 | 221 / 226 | 94% | 90.23 | 381 / 406 |
kidney | 97% | 1111.65 | 86 / 89 | 91% | 77.22 | 820 / 901 |
intestine | 98% | 615.68 | 942 / 966 | 86% | 65.05 | 451 / 527 |
pancreas | 98% | 2841.04 | 322 / 328 | 80% | 27.22 | 143 / 178 |
stomach | 95% | 173.69 | 341 / 359 | 83% | 59.93 | 238 / 286 |
brain | 90% | 104.04 | 2370 / 2642 | 13% | 1.83 | 95 / 705 |
esophagus | 67% | 55.30 | 975 / 1445 | 36% | 11.39 | 65 / 183 |
ovary | 99% | 354.26 | 179 / 180 | 3% | 1.06 | 15 / 430 |
uterus | 82% | 102.57 | 139 / 170 | 12% | 5.03 | 55 / 459 |
skin | 41% | 28.63 | 742 / 1809 | 51% | 10.66 | 239 / 472 |
lung | 50% | 80.03 | 287 / 578 | 41% | 17.63 | 471 / 1155 |
bladder | 62% | 32.81 | 13 / 21 | 28% | 22.25 | 140 / 504 |
eye | 0% | 0 | 0 / 0 | 79% | 21.35 | 63 / 80 |
breast | 57% | 68.36 | 260 / 459 | 6% | 0.92 | 72 / 1118 |
prostate | 62% | 42.25 | 151 / 245 | 0% | 0.05 | 2 / 502 |
blood vessel | 54% | 50.78 | 723 / 1335 | 0% | 0 | 0 / 0 |
heart | 43% | 24.16 | 368 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 12% | 8.76 | 32 / 258 | 7% | 2.21 | 17 / 230 |
adipose | 20% | 11.91 | 237 / 1204 | 0% | 0 | 0 / 0 |
thymus | 5% | 1.87 | 32 / 653 | 0% | 0.03 | 1 / 605 |
peripheral blood | 2% | 2.62 | 19 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 4.00 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001501 | Biological process | skeletal system development |
GO_0005795 | Cellular component | Golgi stack |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0004065 | Molecular function | arylsulfatase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ARSL |
Protein name | Arylsulfatase L Arylsulfatase L (EC 3.1.6.1) (Arylsulfatase E) (ASE) Arylsulfatase E (Chondrodysplasia punctata 1) |
Synonyms | ARSE |
Description | FUNCTION: Exhibits arylsulfatase activity towards the artificial substrate 4-methylumbelliferyl sulfate . May be essential for the correct composition of cartilage and bone matrix during development . Has no activity toward steroid sulfates . . |
Accessions | ENST00000438544.5 ENST00000684077.1 ENST00000381134.9 ENST00000683958.1 C9J5G7 A0A804HHU6 F5GYY5 A0A804HIX6 ENST00000683290.1 A0A804HJF6 ENST00000545496.6 ENST00000672027.1 A0A5F9ZHZ5 A0A804HIF5 ENST00000683677.1 ENST00000684117.1 F5H324 ENST00000684687.1 ENST00000540563.6 A0A5F9ZHU0 P51690 ENST00000672097.1 A0A804HK35 A0A804HJ07 A1L484 ENST00000672606.1 ENST00000673032.1 ENST00000684364.1 ENST00000682364.1 ENST00000672761.1 ENST00000681963.1 ENST00000682184.1 ENST00000540563 ENST00000684738.1 A0A5F9ZHX8 |